Login / Signup
Yue Xiang
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Drug Administration
Patient Reported Outcomes
Radiation Therapy
Abdominal Pain
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Timil H Patel
,
Jamie R Brewer
,
Jiaxin Fan
,
Joyce Cheng
,
Yuan Li Shen
,
Yue Xiang
,
Hong Zhao
,
Steven J Lemery
,
Richard Pazdur
,
Paul G Kluetz
,
Lola A Fashoyin-Aje
FDA Approval Summary: Tremelimumab in combination with durvalumab for the treatment of patients with unresectable hepatocellular carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)